191 related articles for article (PubMed ID: 27338244)
41. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
42. TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease.
Carlson CS; Heagerty PJ; Hatsukami TS; Richter RJ; Ranchalis J; Lewis J; Bacus TJ; McKinstry LA; Schellenberg GD; Rieder M; Nickerson D; Furlong CE; Chait A; Jarvik GP
J Lipid Res; 2006 May; 47(5):1014-24. PubMed ID: 16474172
[TBL] [Abstract][Full Text] [Related]
43. Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake.
Ponce-Ruiz N; Murillo-González FE; Rojas-García AE; Bernal Hernández YY; Mackness M; Ponce-Gallegos J; Barrón-Vivanco BS; Hernández-Ochoa I; González-Arias CA; Ortega Cervantes L; Cardoso-Saldaña G; Medina-Díaz IM
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):40-48. PubMed ID: 31757567
[TBL] [Abstract][Full Text] [Related]
44. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
[TBL] [Abstract][Full Text] [Related]
45. Factors associated to serum paraoxonase 1 activity in patients with cardiovascular disease.
Longo A; Veiga GB; Cousen MIS; Karpinski C; Schneider A; Weber B; Bertoldi EG; Borges LR; Bertacco RTA
Arch Endocrinol Metab; 2021 Nov; 65(6):676-683. PubMed ID: 33844899
[TBL] [Abstract][Full Text] [Related]
46. Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis.
Grubisa I; Otasević P; Dimković N; Nedeljković I; Toljić B; Vucinić N
Srp Arh Celok Lek; 2013; 141(9-10):629-33. PubMed ID: 24364225
[TBL] [Abstract][Full Text] [Related]
47. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia.
Zhu Y; Huang X; Zhang Y; Wang Y; Liu Y; Sun R; Xia M
J Clin Endocrinol Metab; 2014 Feb; 99(2):561-9. PubMed ID: 24285687
[TBL] [Abstract][Full Text] [Related]
48. Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma.
Ergen A; Kılıcoglu O; Ozger H; Agachan B; Isbir T
Mol Biol Rep; 2011 Aug; 38(6):4181-4. PubMed ID: 21104436
[TBL] [Abstract][Full Text] [Related]
49. The role of PON1 and CYP2D6 genes in susceptibility to organophosphorus chronic intoxication in Egyptian patients.
Tawfik Khattab AM; Zayed AA; Ahmed AI; AbdelAal AG; Mekdad AA
Neurotoxicology; 2016 Mar; 53():102-107. PubMed ID: 26723569
[TBL] [Abstract][Full Text] [Related]
50. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
Bhattacharyya T; Nicholls SJ; Topol EJ; Zhang R; Yang X; Schmitt D; Fu X; Shao M; Brennan DM; Ellis SG; Brennan ML; Allayee H; Lusis AJ; Hazen SL
JAMA; 2008 Mar; 299(11):1265-76. PubMed ID: 18349088
[TBL] [Abstract][Full Text] [Related]
51. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
[TBL] [Abstract][Full Text] [Related]
52. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
[TBL] [Abstract][Full Text] [Related]
53. R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.
Mahrooz A; Gohari G; Hashemi MB; Zargari M; Musavi H; Abedini M; Alizadeh A
Mol Biol Rep; 2012 Dec; 39(12):11177-85. PubMed ID: 23054002
[TBL] [Abstract][Full Text] [Related]
54. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
[TBL] [Abstract][Full Text] [Related]
55. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
[TBL] [Abstract][Full Text] [Related]
56. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
57. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.
Leus FR; Wittekoek ME; Prins J; Kastelein JJ; Voorbij HA
Atherosclerosis; 2000 Apr; 149(2):371-7. PubMed ID: 10729387
[TBL] [Abstract][Full Text] [Related]
58. Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.
Han Y; Dorajoo R; Ke T; Ayala B; Chang X; Khor CC; van Dam RM; Yuan JM; Koh WP; Liu J; Goh DY; Friedlander Y; Heng CK
Atherosclerosis; 2015 May; 240(1):40-5. PubMed ID: 25746376
[TBL] [Abstract][Full Text] [Related]
59. Paraoxonase gene polymorphism in south-western Korean population.
Shin BS
J Korean Med Sci; 2009 Aug; 24(4):561-6. PubMed ID: 19654933
[TBL] [Abstract][Full Text] [Related]
60. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA
J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
